000 02916nam a22004335i 4500
001 978-3-642-28965-1
003 DE-He213
005 20140220083314.0
007 cr nn 008mamaa
008 120626s2012 gw | s |||| 0|eng d
020 _a9783642289651
_9978-3-642-28965-1
024 7 _a10.1007/978-3-642-28965-1
_2doi
050 4 _aQD1-999
072 7 _aPN
_2bicssc
072 7 _aSCI013000
_2bisacsh
072 7 _aTEC012000
_2bisacsh
082 0 4 _a540
_223
100 1 _aWendt, Michael D.
_eeditor.
245 1 0 _aProtein-Protein Interactions
_h[electronic resource] /
_cedited by Michael D. Wendt.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2012.
300 _aXVIII, 261 p. 175 illus., 39 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aTopics in Medicinal Chemistry,
_x1862-2461 ;
_v8
505 0 _aProtein-Protein Interactions as Drug Targets -- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics -- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer -- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection -- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus -- Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces -- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.
520 _aMichael D. Wendt Protein-Protein Interactions as Drug Targets Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj Vucic The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto Protein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. Langley Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. Wendt The Discovery of Navitoclax, a Bcl-2 Family Inhibitor
650 0 _aChemistry.
650 1 4 _aChemistry.
650 2 4 _aChemistry/Food Science, general.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642289644
830 0 _aTopics in Medicinal Chemistry,
_x1862-2461 ;
_v8
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-28965-1
912 _aZDB-2-CMS
999 _c102930
_d102930